Andere talen Realcan Pharmaceutical Group Co., Ltd.

Aandelen

002589

CNE1000013X5

slotkoers Shenzhen S.E. Andere beurzen 00:00:00 19-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
2,45 ^CNY	-0,81%		-15,52%	-25,08%

2023	Realcan Pharmaceutical Group Co, Ltd. Rapporteert winstresultaten voor de negen maanden eindigend op 30 september 2023	CI
2023	Realcan Pharmaceutical Group Co, Ltd. Rapporteert winstresultaten voor het halfjaar dat eindigde op 30 juni 2023	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Realcan Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	30-10-23
Realcan Pharmaceutical Group Co., Ltd.(XSEC:002589) added to S&P Global BMI Index	18-09-23
Realcan Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	29-08-23
Realcan Pharmaceutical Group Co., Ltd. Approves the Executive Appointments	22-05-23
Realcan Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	28-04-23
Shanghai Pharmaceutical Co., Ltd. entered into an agreement to acquire 51% stake in Hunan Runji Pharmaceutical Co., Ltd. from Realcan Pharmaceutical Group Co., Ltd. for CNY 149 million	17-01-23
Realcan Pharmaceutical Group Co., Ltd. agreed to acquire 9.6409% of Shandong Lekang Jinyue Industrial Co., Ltd. from Yantai Chenghou Investment Co., Ltd for CNY 84.84 million.	16-12-22
Realcan Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	30-10-22
Realcan Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	29-08-22
Realcan Pharmaceutical Group Co., Ltd. Announces 2021 Final Profit Distribution Plan to Be Implemented (A Shares), Payable on July 22, 2022	14-07-22
Realcan Pharmaceutical Group Co., Ltd.(XSEC:002589) dropped from S&P Global BMI Index	20-06-22
Realcan Pharmaceutical Group Co., Ltd. Approves Cash Dividend for the Year 2021	24-05-22
Realcan Pharmaceutical Group Co., Ltd. Announces Profit Distribution Proposal for 2021	05-05-22
Realcan Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	29-04-22
Realcan Pharmaceutical Group Co., Ltd. agreed to acquire a 38.39992% stake in Tianjin Guohui Big Health Technology Co., Ltd. from Yantai Huishuo Enterprise Management Partnership Enterprise for approximately CNY 230 million.	18-02-22
Realcan Pharmaceutical Group Co., Ltd. acquired Health Technology for approximately CNY 230 million.	17-02-22
Realcan Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021	29-10-21
Realcan Pharmaceutical Group Co., Ltd.(XSEC:002589) dropped from FTSE All-World Index	20-09-21
Realcan Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021	30-08-21
Realcan Pharmaceutical Group Co., Ltd. Announces Cash Dividend on A Shares for the Year 2020, Payable on June 23, 2021	17-06-21

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Realcan Pharmaceutical Group Co., Ltd.

Aandelen

002589

CNE1000013X5

Andere talen

Filters